Gilead Sciences, Inc. - 10%+ Owner at Xilio Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
XLO on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Gilead Sciences, Inc. - trading volume in the past year for Xilio Therapeutics, Inc.

Holdings reported by Gilead Sciences, Inc. for Xilio Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Prefunded Warrants (right to buy) 23.3M $10.4M $1.04 Jun 5, 2025 Direct Common Stock
Common Stock 9.11M $9.47M $1.04 Dec 18, 2024 Direct
Series A Warrants (right to buy) 13.3M Jun 5, 2025 Direct Common Stock
Series B Warrants (right to buy) 13.3M Jun 5, 2025 Direct Common Stock
Series C Warrants (right to buy) 13.3M Jun 5, 2025 Direct Common Stock

Transactions reported by Gilead Sciences, Inc. for Xilio Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.